A Winkelmann1, H Bork2, W Brückle3, C Dexl4, P Heldmann5, P Henningsen6, L Krumbein7, V Pullwitt8, M Schiltenwolf9, W Häuser6,10. 1. Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation, Klinikum der Universität München, München, Deutschland. andreas.winkelmann@med.uni-muenchen.de. 2. Reha-Zentrum, St. Josef-Stift, Sendenhorst, Deutschland. 3. Rheumatologikum, Hannover, Deutschland. 4. Deutsche Fibromyalgie Vereinigung, Seckach, Deutschland. 5. Bundesverband selbstständiger Physiotherapeuten, Bochum, Deutschland. 6. Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Technische Universität München, München, Deutschland. 7. RehaKlinikum Bad Säckingen, Bad Säckingen, Deutschland. 8. Rheumazentrum Mittelhessen, Bad Endbach, Deutschland. 9. Sektion konservative Orthopädie, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland. 10. Innere Medizin I, Klinikum Saarbrücken gGmbH, Saarbrücken, Deutschland.
Abstract
BACKGROUND: The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. METHODS: The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A literature search for systematic reviews of randomized, controlled trials on physiotherapy, occupational therapy and physical therapy from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was achieved by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of available therapies were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. RESULTS AND CONCLUSION: Low to moderate intensity endurance and strength training are strongly recommended. Chiropractic, laser therapy, magnetic field therapy, massage and transcranial magnetic stimulation are not recommended.
BACKGROUND: The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. METHODS: The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A literature search for systematic reviews of randomized, controlled trials on physiotherapy, occupational therapy and physical therapy from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was achieved by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of available therapies were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. RESULTS AND CONCLUSION: Low to moderate intensity endurance and strength training are strongly recommended. Chiropractic, laser therapy, magnetic field therapy, massage and transcranial magnetic stimulation are not recommended.
Authors: A Winkelmann; W Häuser; E Friedel; M Moog-Egan; D Seeger; M Settan; T Weiss; M Schiltenwolf Journal: Schmerz Date: 2012-06 Impact factor: 1.107
Authors: Leonardo M Knijnik; Jairo A Dussán-Sarria; Joanna R Rozisky; Iraci L S Torres; Andre R Brunoni; Felipe Fregni; Wolnei Caumo Journal: Pain Pract Date: 2015-01-12 Impact factor: 3.183
Authors: M Schiltenwolf; U Eidmann; V Köllner; T Kühn; M Offenbächer; F Petzke; M Sarholz; M Weigl; B Wolf; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: Antonio Fraioli; Marcello Grassi; Gioacchino Mennuni; Andrea Geraci; Luisa Petraccia; Mario Fontana; Stefano Conte; Angelo Serio Journal: Ann Ist Super Sanita Date: 2013 Impact factor: 1.663
Authors: Daniel Collado-Mateo; Jose C Adsuar; Pedro R Olivares; Borja Del Pozo-Cruz; Jose A Parraca; Jesus Del Pozo-Cruz; Narcis Gusi Journal: Evid Based Complement Alternat Med Date: 2015-08-17 Impact factor: 2.629
Authors: V Köllner; K Bernardy; W Greiner; L Krumbein; H Lucius; M Offenbächer; M Sarholz; M Settan; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: Carol G T Vance; M Bridget Zimmerman; Dana L Dailey; Barbara A Rakel; Katharine M Geasland; Ruth L Chimenti; Jon M Williams; Meenakshi Golchha; Leslie J Crofford; Kathleen A Sluka Journal: Pain Date: 2021-05-01 Impact factor: 7.926